These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pulmonary hypertension following use of fenfluramine for obesity]. Maesen BL; Snijder RJ; Stricker BH Ned Tijdschr Geneeskd; 1994 Dec; 138(50):2500-2. PubMed ID: 7800076 [TBL] [Abstract][Full Text] [Related]
3. [A case of chronic pulmonary hypertension after fenfluramine intake]. Gaul G; Blazek G; Deutsch E; Heeger H Wien Klin Wochenschr; 1982 Nov; 94(22):618-22. PubMed ID: 7164466 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension and fenfluramine. Douglas JG; Munro JF; Kitchin AH; Muir AL; Proudfoot AT Br Med J (Clin Res Ed); 1981 Oct; 283(6296):881-3. PubMed ID: 6793158 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension, hyperthyroidism, and fenfluramine: a case report and review. Leung YY; Tang KS; Tsang CC; Chan CK; Wong KK; Yu AW MedGenMed; 2006 Nov; 8(4):29. PubMed ID: 17415311 [TBL] [Abstract][Full Text] [Related]
6. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned? Voelkel NF; Clarke WR; Higenbottam T Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009 [No Abstract] [Full Text] [Related]
7. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for obesity -- do the benefits outweigh the risks? Manson JE; Faich GA N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523 [No Abstract] [Full Text] [Related]
10. A close look at fenfluramine and dexfenfluramine. Vivero LE; Anderson PO; Clark RF J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401 [TBL] [Abstract][Full Text] [Related]
11. Fenfluramine-associated hypertension. Mabadeje AF West Afr J Pharmacol Drug Res; 1975 Dec; 2(2):145-52. PubMed ID: 1233823 [TBL] [Abstract][Full Text] [Related]
12. Primary pulmonary hypertension and long-term use of appetite suppressants. Sztuke-Fournier A CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574 [No Abstract] [Full Text] [Related]
13. [Severe pulmonary hypertension complicating a long treatment with dexfenfluramine]. Ferrari E; Drai E; Jourdan J; Sanchez B; Baudouy M; Morand P Arch Mal Coeur Vaiss; 1994 Feb; 87(2):285-6. PubMed ID: 7802538 [TBL] [Abstract][Full Text] [Related]
14. Appetite-suppressant drugs and primary pulmonary hypertension. Fishman AP N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650 [No Abstract] [Full Text] [Related]
15. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity. Anchors M Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245 [No Abstract] [Full Text] [Related]